FDC — 360° view

FDC, a company in the Pharmaceuticals industry, reported revenue of ₹572 crore and net profit of ₹49 crore for the September 2026 quarter.

FDC (NSE: FDC) closed at ₹377.55 on 20 Nov 2026, down 8.8% over the past year. Its market capitalisation is ₹6,147 crore and it trades at 18.7 times earnings.

Share price
₹377.55 (20 Nov 2026)
Market cap
₹6,147 Cr (20 Nov 2026)
P/E
18.71 (20 Nov 2026)
Revenue
₹572 Cr (September 2026 quarter)
Net profit
₹49 Cr (September 2026 quarter)
ROCE
15.4% (FY26)
ROE
11.5% (FY26)
Book value
₹164 (FY26)
Dividend yield
1.32% (last 12 months to 20 Nov 2026)
52-week high / low
₹442.00 / ₹312.95 (20 Nov 2026)
1-year return
-8.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: FDC

FDC (Fairdeal Corporation) Ltd Limited (found in 1936) is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialized formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). .

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.